• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下一代测序技术在神经病学中的应用。

Application of next-generation sequencing technologies in Neurology.

机构信息

1 Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao 266071, China ; 2 College of Medicine and Pharmaceutics, Ocean University of China, Qingdao 266071, China ; 3 Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao 266071, China.

出版信息

Ann Transl Med. 2014 Dec;2(12):125. doi: 10.3978/j.issn.2305-5839.2014.11.11.

DOI:10.3978/j.issn.2305-5839.2014.11.11
PMID:25568878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4260045/
Abstract

Genetic risk factors that underlie many rare and common neurological diseases remain poorly understood because of the multi-factorial and heterogeneous nature of these disorders. Although genome-wide association studies (GWAS) have successfully uncovered numerous susceptibility genes for these diseases, odds ratios associated with risk alleles are generally low and account for only a small proportion of estimated heritability. These results implicated that there are rare (present in <5% of the population) but not causative variants exist in the pathogenesis of these diseases, which usually have large effect size and cannot be captured by GWAS. With the decreasing cost of next-generation sequencing (NGS) technologies, whole-genome sequencing (WGS) and whole-exome sequencing (WES) have enabled the rapid identification of rare variants with large effect size, which made huge progress in understanding the basis of many Mendelian neurological conditions as well as complex neurological diseases. In this article, recent NGS-based studies that aimed to investigate genetic causes for neurological diseases, including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, stroke, amyotrophic lateral sclerosis and spinocerebellar ataxias, have been reviewed. In addition, we also discuss the future directions of NGS applications in this article.

摘要

遗传风险因素是许多罕见和常见神经疾病的基础,但由于这些疾病具有多因素和异质性的特点,因此仍了解甚少。尽管全基因组关联研究(GWAS)成功地发现了许多这些疾病的易感基因,但与风险等位基因相关的优势比通常较低,仅占估计遗传率的一小部分。这些结果表明,这些疾病的发病机制中存在罕见(存在于<5%的人群中)但并非致病的变异,这些变异通常具有较大的效应大小,无法通过 GWAS 捕获。随着下一代测序(NGS)技术成本的降低,全基因组测序(WGS)和全外显子组测序(WES)已经能够快速识别具有较大效应大小的罕见变异,这在理解许多孟德尔神经疾病以及复杂神经疾病的基础方面取得了巨大进展。在本文中,回顾了最近基于 NGS 的研究,这些研究旨在探讨神经疾病的遗传原因,包括阿尔茨海默病、帕金森病、癫痫、多发性硬化症、中风、肌萎缩侧索硬化症和脊髓小脑共济失调。此外,我们还在本文中讨论了 NGS 应用的未来方向。

相似文献

1
Application of next-generation sequencing technologies in Neurology.下一代测序技术在神经病学中的应用。
Ann Transl Med. 2014 Dec;2(12):125. doi: 10.3978/j.issn.2305-5839.2014.11.11.
2
Next-Generation Sequencing Technologies and Neurogenetic Diseases.下一代测序技术与神经遗传性疾病
Life (Basel). 2021 Apr 19;11(4):361. doi: 10.3390/life11040361.
3
Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.全基因组分析鉴定的功能疾病因果/易感变异在理解人类疾病中的意义。
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(9):657-676. doi: 10.2183/pjab.93.042.
4
Application of Next-Generation Sequencing in Neurodegenerative Diseases: Opportunities and Challenges.下一代测序技术在神经退行性疾病中的应用:机遇与挑战
Neuromolecular Med. 2021 Jun;23(2):225-235. doi: 10.1007/s12017-020-08601-7. Epub 2020 May 12.
5
Neurology Individualized Medicine: When to Use Next-Generation Sequencing Panels.神经病学个性化医疗:何时使用新一代测序面板。
Mayo Clin Proc. 2017 Feb;92(2):292-305. doi: 10.1016/j.mayocp.2016.09.008.
6
Family studies to find rare high risk variants in migraine.寻找偏头痛中罕见高风险变异的家族研究。
J Headache Pain. 2017 Dec;18(1):32. doi: 10.1186/s10194-017-0729-y. Epub 2017 Mar 2.
7
The challenge for the next generation of medical geneticists.下一代医学遗传学家面临的挑战。
Hum Mutat. 2014 Aug;35(8):909-11. doi: 10.1002/humu.22592. Epub 2014 Jun 28.
8
What we have learned from the next-generation sequencing: Contributions to the genetic diagnoses and understanding of pathomechanisms of neurodegenerative diseases.我们从下一代测序中学到了什么:对神经退行性疾病的基因诊断和发病机制理解的贡献。
J Neurogenet. 2015;29(2-3):103-12. doi: 10.3109/01677063.2015.1060972. Epub 2015 Jul 9.
9
Whole exome sequencing: Uncovering causal genetic variants for ocular diseases.全外显子组测序:揭示眼部疾病的致病基因变异
Exp Eye Res. 2017 Nov;164:139-150. doi: 10.1016/j.exer.2017.08.013. Epub 2017 Aug 24.
10
Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes.用于癫痫综合征诊断的新一代测序方法
Front Genet. 2018 Feb 7;9:20. doi: 10.3389/fgene.2018.00020. eCollection 2018.

引用本文的文献

1
Lack of association between the rs1842681 polymorphism of the LOC105372028 gene and functional outcomes after stroke.LOC105372028基因的rs1842681多态性与中风后功能结局之间无关联。
Sci Rep. 2025 Aug 24;15(1):31136. doi: 10.1038/s41598-025-14789-0.
2
Genes to therapy: a comprehensive literature review of whole-exome sequencing in neurology and neurosurgery.从基因到治疗:神经科和神经外科全外显子组测序的全面文献综述。
Eur J Med Res. 2024 Nov 10;29(1):538. doi: 10.1186/s40001-024-02063-4.
3
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches.揭开神经紊乱遗传图谱之谜:深入了解发病机制、变异鉴定技术及治疗方法。
Int J Mol Sci. 2024 Feb 15;25(4):2320. doi: 10.3390/ijms25042320.
4
A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson's Disease.一项针对西西里岛帕金森病患者队列的二代测序研究。
Biomedicines. 2023 Nov 22;11(12):3118. doi: 10.3390/biomedicines11123118.
5
Brain lipidomics: From functional landscape to clinical significance.脑脂质组学:从功能图谱到临床意义。
Sci Adv. 2022 Sep 16;8(37):eadc9317. doi: 10.1126/sciadv.adc9317.
6
Advancements in Genomic and Behavioral Neuroscience Analysis for the Study of Normal and Pathological Brain Function.用于研究正常和病理脑功能的基因组学与行为神经科学分析进展
Front Mol Neurosci. 2022 Jun 23;15:905328. doi: 10.3389/fnmol.2022.905328. eCollection 2022.
7
and Polymorphisms are Associated with Ischemic Stroke Susceptibility and Post-Stroke Mortality.并且多态性与缺血性中风易感性和中风后死亡率相关。
Diagnostics (Basel). 2020 Nov 13;10(11):947. doi: 10.3390/diagnostics10110947.
8
Application of Next-Generation Sequencing in Neurodegenerative Diseases: Opportunities and Challenges.下一代测序技术在神经退行性疾病中的应用:机遇与挑战
Neuromolecular Med. 2021 Jun;23(2):225-235. doi: 10.1007/s12017-020-08601-7. Epub 2020 May 12.
9
Whole-Exome Sequencing in 22 Young Ischemic Stroke Patients With Familial Clustering of Stroke.22 例有家族性卒中聚集的青年缺血性卒中患者的全外显子组测序。
Stroke. 2020 Apr;51(4):1056-1063. doi: 10.1161/STROKEAHA.119.027474. Epub 2020 Mar 16.
10
Identification of key genes by integrating DNA methylation and next-generation transcriptome sequencing for esophageal squamous cell carcinoma.通过整合 DNA 甲基化和下一代转录组测序鉴定食管鳞状细胞癌的关键基因。
Aging (Albany NY). 2020 Jan 21;12(2):1332-1365. doi: 10.18632/aging.102686.

本文引用的文献

1
Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease).常染色体隐性遗传性脊髓小脑共济失调 7 型(SCAR7)是由 TPP1 基因中的变异引起的,该基因与经典的晚发性婴儿神经元蜡样脂褐质沉积症 2 型(CLN2 疾病)有关。
Hum Mutat. 2013 May;34(5):706-13. doi: 10.1002/humu.22292. Epub 2013 Mar 11.
2
Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease.帕金森病中 EIF4G1 和 VPS35 稀有变异的全外显子组测序。
Neurology. 2013 Mar 12;80(11):982-9. doi: 10.1212/WNL.0b013e31828727d4. Epub 2013 Feb 13.
3
TREM2 in Alzheimer's disease.TREM2 在阿尔茨海默病中的作用。
Mol Neurobiol. 2013 Aug;48(1):180-5. doi: 10.1007/s12035-013-8424-8. Epub 2013 Feb 14.
4
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.TREM2 R47H 变体是早发性阿尔茨海默病的风险因素。
J Alzheimers Dis. 2013;35(1):45-9. doi: 10.3233/JAD-122311.
5
Next-generation sequencing in understanding complex neurological disease.下一代测序在理解复杂神经疾病中的应用。
Expert Rev Neurother. 2013 Feb;13(2):215-27. doi: 10.1586/ern.12.165.
6
Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.KCnd3 钾通道基因突变导致 19 型脊髓小脑共济失调。
Ann Neurol. 2012 Dec;72(6):870-80. doi: 10.1002/ana.23700.
7
Mutations in KCND3 cause spinocerebellar ataxia type 22.KCND3 基因突变导致脊髓小脑共济失调 22 型。
Ann Neurol. 2012 Dec;72(6):859-69. doi: 10.1002/ana.23701.
8
DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability.DNAJC6 负责具有表型可变性的青少年帕金森病。
Parkinsonism Relat Disord. 2013 Mar;19(3):320-4. doi: 10.1016/j.parkreldis.2012.11.006. Epub 2012 Dec 2.
9
Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis.VCP 基因的新突变导致非典型肌萎缩侧索硬化症。
Neurology. 2012 Nov 27;79(22):2201-8. doi: 10.1212/WNL.0b013e318275963b. Epub 2012 Nov 14.
10
TREM2 variants in Alzheimer's disease.TREM2 变体在阿尔茨海默病中的作用。
N Engl J Med. 2013 Jan 10;368(2):117-27. doi: 10.1056/NEJMoa1211851. Epub 2012 Nov 14.